Anti-CCP is a specific antibody that targets cyclic citrullinated peptides, proteins that have undergone a chemical modification known as citrullination. The presence of anti-CCP antibodies is a highly specific marker for rheumatoid arthritis (RA). While not all patients with RA will test positive for anti-CCP, a positive test can significantly increase the likelihood of a diagnosis. Anti-CCP is often used in combination with other diagnostic tests, such as rheumatoid factor (RF), to confirm the presence of RA and to predict disease progression.

Angiotensin-converting enzyme (ACE) is a key component of the renin-angiotensin system, a vital pathway regulating blood pressure. It converts the inactive hormone angiotensin I into the potent vasoconstrictor angiotensin II, which narrows blood vessels, leading to increased blood pressure. ACE inhibitors, a class of medications, block this conversion, thereby lowering blood pressure and reducing the strain on the heart. These drugs are commonly used to treat hypertension, heart failure, and other cardiovascular conditions.

An anti-nuclear antibody (ANA) profile is a blood test that detects antibodies produced by the immune system that mistakenly target the bodys own cell nuclei.Elevated ANA levels can indicate the presence of an autoimmune disease, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, or Sjogrens syndrome. The test measures both the presence and pattern of ANA, with different patterns associated with specific autoimmune conditions. A positive ANA test often requires further evaluation to confirm a diagnosis.